Detection of cancer in cervical tissue biopsies using mobile lipid resonances measured with diffusion-weighted 1H magnetic resonance spectroscopy

NMR in Biomedicine

Volumn 23, Issue 4, 2010, Pages 382-390

  Zietkowski, D ^a   Davidson, R L ^a   Eykyn, T R ^a   De Silva, S S ^a   DeSouza, N M ^a   Payne, G S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

1H MRS; Cervix; Diffusion weighting; HR MAS; Mobile lipid resonances

Indexed keywords

1H MRS; AREA UNDER THE CURVES; CANCER TISSUES; CERVICAL CANCERS; CERVICAL CARCINOMA; CERVICAL TISSUES; CERVIX; DIFFUSION COEFFICIENTS; DIFFUSION WEIGHTING; ECHO SEQUENCES; GRADIENT STRENGTH; HIGH RESOLUTION MAGIC ANGLE SPINNING; HIGH SENSITIVITY; LINEAR DISCRIMINANT ANALYSIS; LIPID SYSTEMS; LOW MOLECULAR WEIGHT; PEAK AREA; RECEIVER OPERATING CHARACTERISTIC CURVES; SIGNAL LOSS; SPECTRAL OVERLAP; VISUALISATION;

BIOPSY; CHEMICAL ANALYSIS; DIELECTRIC WAVEGUIDES; DISCRIMINANT ANALYSIS; HISTOLOGY; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; RESONANCE; TISSUE; VISUALIZATION;

DIFFUSION;

LINOLEIC ACID; OLEIC ACID; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

ARTICLE; BIOPSY; CANCER DIAGNOSIS; CANCER TISSUE; CARCINOGENESIS; CLINICAL EVALUATION; DIAGNOSTIC PROCEDURE; DIFFUSION COEFFICIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOBILE LIPID RESONANCE; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA;

BIOPSY; CERVIX UTERI; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LIPIDS; ROC CURVE; UTERINE CERVICAL NEOPLASMS;

EID: 77951609680     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1472     Document Type: Article

References (44)

1. Negendank W, Sauter R. Intratumoral lipids in 1H MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial. Anticancer Res. 1996; 16: 1533-1538. (Pubitemid 26257823)
2. Kvistad KA, Bakken IJ, Gribbestad IS, Ehrnholm B, Lundgren S, Fjosne HE, Haraldseth O. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J. Magn. Reson. Imaging 1999; 10: 159-164.
3. Mahon MM, Williams AD, Soutter WP, Cox IJ, McIndoe GA, Coutts GA, Dina R, deSouza NM. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration. NMR Biomed. 2004; 17: 1-9.
4. Mountford CE, Doran S, Lean CL, Russell P. Proton MRS can determine the pathology of human cancers with a high level of accuracy. Chem. Rev. 2004; 104: 3677-3704.
5. Mountford CE, Tattersall MH. Proton magnetic resonance spectroscopy and tumour detection. Cancer Surveys 1987; 6: 285-314.
6. Barba I, Cabanas ME, Arus C. The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells. Cancer Res. 1999; 59: 1861-1868. (Pubitemid 29186158)
7. Barba I, Mann P, Cabanas ME, Arus C, Gasparovic C. Mobile lipid production after confluence and pH stress in perfused C6 cells. NMR Biomed. 2001; 14: 33-40.
8. Rosi A, Grande S, Luciani AM, Barone P, Mlynarik V, Viti V, Guidoni L. (1H) MRS studies of signals from mobile lipids and from lipid metabolites: comparison of the behavior in cultured tumor cells and in spheroids. NMR Biomed. 2004; 17: 76-91. (Pubitemid 38477098)
9. Blankenberg FG, Katsikis PD, Storrs RW, Beaulieu C, Spielman D, Chen JY, Naumovski L, Tait JF. Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood 1997; 89: 3778-3786. (Pubitemid 27227102)
10. Bezabeh T, Mowat MR, Jarolim L, Greenberg AH, Smith IC. Detection of drug-induced apoptosis and necrosis in human cervical carcinoma cells using 1H NMR spectroscopy. Cell Death Differentiation 2001; 8: 219-224. (Pubitemid 32288167)
11. Al-Saffar NM, Titley JC, Robertson D, Clarke PA, Jackson LE, Leach MO, Ronen SM. Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells. Br. J. Cancer 2002; 86: 963-970. (Pubitemid 34271034)
12. Milkevitch M, Shim H, Pilatus U, Pickup S, Wehrle JP, Samid D, Poptani H, Glickson JD, Delikatny EJ. Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells. Biochimica et Biophysica Acta 2005; 1734: 1-12. (Pubitemid 40615215)
13. Zoula S, Herigault G, Ziegler A, Farion R, Decorps M, Remy C. Correlation between the occurrence of 1H-MRS lipid signal, necrosis and lipid droplets during C6 rat glioma development. NMR Biomed. 2003; 16: 199-212. (Pubitemid 37265323)
14. Opstad KS, Bell BA, Griffiths JR, Howe FA. An investigation of human brain tumour lipids by high-resolution magic angle spinning 1H MRS and histological analysis. NMR Biomed. 2008; 21: 677-685.
15. Mountford CE, Delikatny EJ, Dyne M, Holmes KT, Mackinnon WB, Ford R, Hunter JC, Truskett ID, Russell P. Uterine cervical punch biopsy specimens can be analyzed by 1H MRS. Magn. Reson. Med. 1990; 13: 324-331.
16. Mahon MM, deSouza NM, Dina R, Soutter WP, McIndoe GA, Williams AD, Cox IJ. Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study. NMR Biomed. 2004; 17: 144-153.
17. Sitter B, Bathen T, Hagen B, Arentz C, Skjeldestad FE, Gribbestad IS. Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy. Magma 2004; 16: 174-181. (Pubitemid 38657623)
18. Cheng LL, Wu C, Smith MR, Gonzalez RG. Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T. FEBS Lett. 2001; 494: 112-116. (Pubitemid 32289382)
19. Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed. 2006; 19: 30-40. (Pubitemid 43250787)
20. Behar KL, Rothman DL, Spencer DD, Petroff OA. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn. Reson. Med. 1994; 32: 294-302.
21. Hwang JH, Graham GD, Behar KL, Alger JR, Prichard JW, Rothman DL. Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain. Magn. Reson. Med. 1996; 35: 633-639.
22. Seeger U, Klose U, Mader I, Grodd W, Nagele T. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases. Magn. Reson. Med. 2003; 49: 19-28.
23. Weybright P, Millis K, Campbell N, Cory DG, Singer S. Gradient, high-resolution, magic angle spinning 1H nuclear magnetic resonance spectroscopy of intact cells. Magn. Reson. Med. 1998; 39: 337-345.
24. Millis KK, Maas WE, Cory DG, Singer S. Gradient, high-resolution, magic-angle spinning nuclear magnetic resonance spectroscopy of human adipocyte tissue. Magn. Reson. Med. 1997; 38: 399-403.
25. Millis K, Weybright P, Campbell N, Fletcher JA, Fletcher CD, Cory DG, Singer S. Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy. Magn. Reson. Med. 1999; 41: 257-267.
26. Griffin JL, Williams HJ, Sang E, Nicholson JK. Abnormal lipid profile of dystrophic cardiac tissue as demonstrated by one- and twodimensional magic-angle spinning (1)H NMR spectroscopy. Magn. Reson. Med. 2001; 46: 249-255.
27. Schmitz JE, Kettunen MI, Hu DE, Brindle KM. 1H MRS-visible lipids accumulate during apoptosis of lymphoma cells in vitro and in vivo. Magn. Reson. Med. 2005; 54: 43-50.
28. Milkevitch M, Jeitner TM, Beardsley NJ, Delikatny EJ. Lovastatin enhances phenylbutyrate-induced MR-visible glycerophosphocholine but not apoptosis in DU145 prostate cells. Biochimica et Biophysica Acta 2007; 1771: 1166-1176. (Pubitemid 47404967)
29. Jerschow A, Muller N. Suppression of convection artifacts in stimulated-echo diffusion experiments. Double-stimulated-echo experiments. J. Magn. Reson. 1997; 125: 372-375.
30. Jerschow A, Muller N. Diffusion-separated nuclear magnetic resonance spectroscopy of polymer mixtures. Macromolec. 1998; 31: 6573-6578. (Pubitemid 128567943)
31. Mahon MM, Cox IJ, Dina R, Soutter WP, McIndoe GA, Williams AD, deSouza NM. (1)H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: in vivo-ex vivo profiles and effect of tumor load. J. Magn. Reson. Imaging 2004; 19: 356-364.
32. Fisher RA. The use of multiple measurements in taxonomic problems. Ann. Eugenic. 1936; 7.
33. Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning, 1st edn. Springer Science: 2001.
34. Hatzakis E, Koidis A, Boskou D, Dais P. Determination of phospholipids in olive oil by 31P NMR spectroscopy. J. Agricultural Food Chem. 2008; 56: 6232-6240.
35. Sivaraja M, Turner C, Souza K, Singer S. Ex vivo two-dimensional proton nuclear magnetic resonance spectroscopy of smooth muscle tumors: advantages of total correlated spectroscopy over homonuclear J-correlated spectroscopy. Cancer Res. 1994; 54: 6037-6040. (Pubitemid 24378623)
36. Hakumaki JM, Kauppinen RA. 1H NMR visible lipids in the life and death of cells. Trends Biochem. Sci. 2000; 25: 357-362.
37. Delikatny EJ, Russell P, Hunter JC, Hancock R, Atkinson KH, van Haaften-Day C, Mountford CE. Proton MR and human cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions. Radiology 1993; 188: 791-796. (Pubitemid 23254603)
38. Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M, Wilkins P, Opstad KS, Doyle VL, McLean MA, Bell BA, Griffiths JR. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn. Reson. Med. 2003; 49: 223-232.
39. Astrakas LG, Zurakowski D, Tzika AA, Zarifi MK, Anthony DC, De Girolami U, Tarbell NJ, Black PM. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Clin. Cancer. Res. 2004; 10: 8220-8228.
40. Righi V, Mucci A, Schenetti L, Tosi MR, Grigioni WF, Corti B, Bertaccini A, Franceschelli A, Sanguedolce F, Schiavina R, Martorana G, Tugnoli V. Ex vivo HR-MAS magnetic resonance spectroscopy of normal and malignant human renal tissues. Anticancer Res. 2007; 27: 3195-3204. (Pubitemid 47607542)
41. Calabrese C, Pisi A, Di Febo G, Liguori G, Filippini G, Cervellera M, Righi V, Lucchi P, Mucci A, Schenetti L, Tonini V, Tosi MR, Tugnoli V. Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy. Cancer Epidemiol. Biomarkers Prev. 2008; 17: 1386-1395.
42. Righi V, Durante C, Cocchi M, Calabrese C, Di Febo G, Lecce F, Pisi A, Tugnoli V, Mucci A, Schenetti L. Discrimination of healthy and neoplastic human colon tissues by ex vivo HR-MAS NMR spectroscopy and chemometric analyses. J. Proteome Res. 2009; 8: 1859-1869.
43. Kolwijck E, Engelke UF, van der Graaf M, Heerschap A, Blom HJ, Hadfoune M, Buurman WA, Massuger LF, Wevers RA. N-acetyl resonances in in vivo and in vitro NMR spectroscopy of cystic ovarian tumors. NMR Biomed 2009; 22: 1093-1099.
44. Charles-Edwards EM, Messiou C, Morgan VA, De Silva SS, McWhinney NA, Katesmark M, Attygalle AD, DeSouza NM. Diffusion-weighted imaging in cervical cancer with an endovaginal technique: potential value for improving tumor detection in stage Ia and Ib1 disease. Radiology 2008; 249: 541-550.